Clinical Trial Update: Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis [Phase 3]

View source ↗

Summary

A Phase 3 trial conducted by All India Institute of Medical Sciences evaluating thrice-weekly Directly Observed Treatment, Short-Course (DOTS) for HIV-associate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Ethambutol (ethambutol)
• ISONIAZID (ISONIAZID)
• Pyrazinamide (pyrazinamide)
• Rifampicin

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | Status: COMPLETED